Evan Konyen (F) from Sudbury Wolves to Flint Firebirds
Date: 06/04/2024
Player: Evan Konyen (F)
From: Sudbury Wolves
To: Flint Firebirds
Source: You need a free account to view Transfer URL Sign In/Up
Date: 06/04/2024
Player: Evan Konyen (F)
From: Sudbury Wolves
To: Flint Firebirds
Source: You need a free account to view Transfer URL Sign In/Up
Date: 06/04/2024
Player: Nolan Collins (D)
From: Sudbury Wolves
To: Flint Firebirds
Source: You need a free account to view Transfer URL Sign In/Up
Date: 06/04/2024
Player: Matthew Mania (D)
From: Sudbury Wolves
To: Flint Firebirds
Source: You need a free account to view Transfer URL Sign In/Up
Date: 06/04/2024
Player: Joshua Colosimo (F)
From: Sudbury Wolves
To: Flint Firebirds
Information: Player's Rights
Source: You need a free account to view Transfer URL Sign In/Up
Date: 06/04/2024
Player: Cannon Sinclair (F)
From: Cold Lake Aeros
To: Kirkland Lake Gold Miners
Source: You need a free account to view Transfer URL Sign In/Up
Date: 06/04/2024
Player: Aaron Leenaars (F)
From: Stayner Siskins
To: Kirkland Lake Gold Miners
Source: You need a free account to view Transfer URL Sign In/Up
Date: 06/04/2024
Player: John Moberg (F)
From: Nyköpings SK
To: HC Vita Hästen
Source: You need a free account to view Transfer URL Sign In/Up
This Viewpoint discusses recommendations from the US Centers for Disease Control and Prevention for newly licensed immunizations for respiratory syncytial virus in infants, children with high-risk conditions, and older adults.
This study of individual participant data from 6 pooled cohorts assesses whether resolution of elevated childhood non–high-density lipoprotein cholesterol (non–HDL-C) by adulthood is associated with reduced risk of clinical cardiovascular disease (CVD) events.
In Reply We appreciate letters about our Review on thyroid cancer. In response to the comments by Drs Beheshtirouy and Shayanfar, the causal association between GLP-1 RA use and thyroid cancer is complex and requires careful consideration of factors that directly or indirectly influence carcinogenesis pathways such as the direct biological effects of the drug, host susceptibility factors (eg, obesity or proinflammatory states), biases embedded in clinical trials, and length of follow-up. To date... Читать дальше...
To the Editor A recent Review discussed the complexity of thyroid cancer. First, we would like to highlight the importance of distinguishing between benign and malignant thyroid nodules preoperatively.
This study examines substances identified during testing of counterfeit prescription pills seized by law enforcement in Rhode Island from 2017 to 2022.
This JAMA Arts and Medicine feature describes ways in which Fritz Kahn shared a prescient and nuanced vision of technology’s role in the patient-physician interaction, a topic of continued interest and relevance today, through his illustrations.
This Viewpoint discusses the importance of researcher access to federal health care data following a CMS decision to limit the use of physical data and proposes solutions to maintain access and security.
Again left fingers enter the chest
In Reply We thank Drs Schoenmakers and Fraser for their comments on our study. We reported the US experience with denosumab administration among dialysis-dependent patients, finding the weighted cumulative incidence of severe hypocalcemia (ie, <7.5 mg/dL or emergent care) at 12 weeks to be 41.1% with denosumab. We agree that treatment for osteoporosis in our study may have been initiated in some patients with poorly controlled CKD-MBD, highlighting the importance of increased attention to careful patient selection in clinical practice. Читать дальше...
To the Editor We have some concerns about the recent retrospective public health surveillance study of older female dialysis-dependent patients who were treated with denosumab for osteoporosis.
This cross-sectional study assesses the prevalence and temporal evolution of cardiovascular-kidney-metabolic syndrome stages.
A 3-year-old had spontaneous gingival hemorrhage and bilateral limb weakness with inability to bear weight. He had no preceding oral trauma or recent infection, took no regular medications, and had no recent use of aspirin or nonsteroidal anti-inflammatory drugs; his diet was limited to primarily chicken nuggets and milk. What is the diagnosis and what would you do next?
In this narrative medicine essay, a lecturer in narrative medicine strives to accept her best self by surmounting the barriers of itchy skin and unsightly red patches caused by chronic atopic dermatitis.
This randomized trial assesses the effect of ponatinib vs imatinib combined with low-intensity chemotherapy on disease remission in adults with newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia (ALL).
The refreshing influence of the weekly recurring “day of rest” on a person subjected to the strenuous routine of a busy life is a feature which he himself can duly appreciate in terms of his “feelings” and “spirits.” If it is desired to demonstrate the need of such relaxation and the benefits derived therefrom in some objective way, a method is not easily forthcoming. The problem is one which, in its broadest aspects, has a far-reaching importance in every community. The efficiency of the working man... Читать дальше...
This JAMA Insights article reviews Americans with Disabilities Act (ADA) rules for patients, visitors, and other members of the public bringing service animals into health care settings.
In this issue of JAMA, Jabbour and colleagues report results from the interim analysis of the PhALLCON randomized trial with ponatinib vs imatinib, combined with reduced-intensity chemotherapy. They found ponatinib to have superior efficacy and a comparable safety profile for frontline treatment of adults with newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL). On the heels of these results, the US Food and Drug Administration granted ponatinib accelerated approval for this indication on March 19, 2024.
This JAMA Patient Page describes allergic skin reactions from contact with poison ivy, poison oak, and poison sumac plants, and how to treat rashes caused by these plants.